You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune System Diseases

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,

Recruiting
  • Primary Immune Regulatory Disorder
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 15, 2023

Upper Extremity Function in Multiple Sclerosis Advanced

Active, not recruiting
  • Multiple Sclerosis
  • +7 more
  • Tampa, Florida
    Carol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022

Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Recruiting
  • Spinal Cord Injuries
  • +4 more
    • Manhasset, New York
      Northwell Health
    May 24, 2023

    Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders (Including Diabetes) Trial in Canada (Support-t)

    Not yet recruiting
    • Diabetes Mellitus
    • +6 more
    • Support-t
    • Gatineau, Canada
    • +3 more
    Jun 16, 2023

    Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis Trial in Australia (PVX-108, Placebo)

    Not yet recruiting
    • Peanut Allergy
    • +3 more
    • PVX-108
    • Placebo
    • Randwick, New South Wales, Australia
    • +4 more
    Jan 29, 2023

    Medically Assisted Fertilization Techniques in Systemic

    Recruiting
    • Rheumatic Diseases
    • +4 more
    • collection and analysis of treatments and procedures already performed by normal clinical practice
    • Milan, Italy
      San Raffaele Hospital
    Mar 28, 2023

    Immune System Disorder (Healthy Volunteer) Trial in Baltimore (Belumosudil mesylate, Placebo)

    Completed
    • Immune System Disorder (Healthy Volunteer)
    • Belumosudil mesylate
    • Placebo
    • Baltimore, Maryland
      Investigational site
    Jun 15, 2023

    Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

    Recruiting
    • Lymphoma
    • +4 more
    • iC9-CAR19 T cells
    • +4 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 2, 2022

    Characterize Patients Treated at Internal Medicine Clinics

    Recruiting
    • Respiratory Disease
    • +7 more
    • Inpatient or Outpatient visit
    • Milan, Italy
    • +1 more
    Mar 24, 2023

    Postural Tachycardia Syndrome Trial in La Jolla (Time restricted eating)

    Recruiting
    • Postural Tachycardia Syndrome
    • Time restricted eating
    • La Jolla, California
      Altman Clinical and Translational Research Institute
    Aug 3, 2022

    Immune System Disorder (Healthy Volunteer) Trial in Buffalo (Belumosudil mesylate, Placebo)

    Completed
    • Immune System Disorder (Healthy Volunteer)
    • Belumosudil mesylate
    • Placebo
    • Buffalo, New York
      Investigational site
    Jun 15, 2023

    Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • iC9-CAR19 cells
    • +3 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 21, 2022

    Immunity Disorders, Aging, Inflammation Trial in Bainbridge Island (HTB Rejuvenate)

    Completed
    • Immunity Disorders
    • +2 more
    • HTB Rejuvenate
    • Bainbridge Island, Washington
      Big Bold Health PBC
    Dec 5, 2022

    Immune System Disorder (Healthy Volunteer) Trial in Buffalo (Belumosudil mesylate, Placebo)

    Completed
    • Immune System Disorder (Healthy Volunteer)
    • Belumosudil mesylate
    • Placebo
    • Buffalo, New York
      Investigational site
    Jun 15, 2023

    Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

    Recruiting
    • Lymphoma
    • +7 more
    • ATLCAR.CD30 cells
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 2, 2022

    Sensitivity and Specificity of TSA-CBA for Autoantibodies

    Recruiting
    • NMO Spectrum Disorder
    • +6 more
    • CBA-TSA
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Jun 8, 2022

    Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,

    Recruiting
    • Malignancy
    • +2 more
    • Biospecimen Collection
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Feb 11, 2022

    Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

    Recruiting
    • Primary T-cell Immunodeficiency Disorders
    • +4 more
    • Immunosuppression Only Conditioning -Closed with amendment L
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Jul 26, 2022

    Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Montreal (Group education sessions for parents plus usual

    Not yet recruiting
    • Diabetes Mellitus
    • +6 more
    • Group education sessions for parents plus usual diabetes care
    • Usual diabetes care
    • Montreal, Quebec, Canada
      Montreal Children's Hospital - McGill University Health Centre (
    Jul 6, 2022

    Plasmodium Malariae Infection, SMC, Immune System Disease Trial in Parakou (saisonal malaria chimoprevention)

    Completed
    • Plasmodium Malariae Infection
    • +2 more
    • saisonal malaria chimoprevention
    • Parakou, Benin
      Azizath MOUSSILIOU
    Dec 25, 2022

    Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • +7 more
    • (no location specified)
    Jun 21, 2022

    Gulf Long-Term Follow-Up Study

    Active, not recruiting
    • Cardiovascular Disease
    • +4 more
      • Durham, North Carolina
        Social & Scientific Systems
      Aug 24, 2022

      Immune System Diseases Trial in Lugo (10 HEP/mL Betula verrucosa allergen extract, 25 HEP/mL Betula verrucosa allergen extract,

      Completed
      Has Results
      • Immune System Diseases
      • 10 HEP/mL Betula verrucosa allergen extract
      • +3 more
      • Lugo, Galicia, Spain
        Hospital Lucus Augusti
      May 4, 2022

      Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)

      Recruiting
      • Immunoglobulin A Nephropathy
      • +5 more
      • Leicester, United Kingdom
        Leicester General Hospital, University Hospitals of Leicester NH
      May 18, 2022

      Healthy, Gastrointestinal Diseases Trial in Singapore (Placebo, HMO 1, HMO 2)

      Recruiting
      • Healthy
      • Gastrointestinal Diseases
      • Placebo
      • +2 more
      • Singapore, Singapore
        Singapore Institute for Clinical Trials
      Oct 16, 2023